Cargando…

Mo1423: PATIENT PERSPECTIVES ON REMOTE HYPNOTHERAPY FOR IRRITABLE BOWEL SYNDROME DURING THE COVID-19 PANDEMIC: THE 'NEW NORM’ OR JUST A TEMPORARY SOLUTION?

Detalles Bibliográficos
Autores principales:	Noble, Hithin, Hasan, Syed S., Whorwell, Peter J., Vasant, Dipesh H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2022
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212683/ http://dx.doi.org/10.1016/S0016-5085(22)61814-6

Ejemplares similares

Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice
por: Noble, Hithin, et al.
Publicado: (2022)

Gut-focused hypnotherapy for children and adolescents with irritable bowel syndrome
por: Vasant, Dipesh H, et al.
Publicado: (2020)

The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID‐19 pandemic
por: Noble, Hithin, et al.
Publicado: (2022)

Experience and clinical efficacy of gut‐directed hypnotherapy in an Asian population with refractory irritable bowel syndrome
por: Sasegbon, Ayodele, et al.
Publicado: (2022)

Six vs 12 Sessions of Gut-focused Hypnotherapy for Irritable Bowel Syndrome: A Randomized Trial
por: Hasan, Syed S., et al.
Publicado: (2021)

Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions
por: Donnet, Anne-Sophie, et al.
Publicado: (2022)

SKYPE HYPNOTHERAPY FOR IRRITABLE BOWEL SYNDROME: Effectiveness and Comparison with Face-to-Face Treatment
por: Hasan, Shariq S., et al.
Publicado: (2019)

Gut‐focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence‐base, practical aspects, and the Manchester Protocol
por: Vasant, Dipesh H., et al.
Publicado: (2019)

Mood color choice helps to predict response to hypnotherapy in patients with irritable bowel syndrome
por: Carruthers, Helen R, et al.
Publicado: (2010)

Mo1088: DIFFERENCES BETWEEN FUNCTIONAL CONSTIIPATION AND CONSTIPATION-PREDOMNANT IRRITABLE BOWEL SYNDROME WITH FOCUS PERFERCTIONISM BY STATISTICAL FACTOR ANALYSIS
por: Yamamoto, Sayuri, et al.
Publicado: (2022)

A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study)
por: Flik, Carla E, et al.
Publicado: (2011)

Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?
por: Purssell, Huw, et al.
Publicado: (2021)

Mo1055: COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS INFLIXIMAB FOR INFLAMMATORY BOWEL DISEASES IN SEQUENCIAL BIOLOGICAL TREATMENT
por: Baik, Deborah, et al.
Publicado: (2022)

Su093 GUT-BRAIN AXIS AND IRRITABLE BOWEL SYNDROME DURING SARS COV-2 PANDEMIC. A SURVEY BASED STUDY.
por: Piskorz, Maria, et al.
Publicado: (2021)

Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy
por: Peter, Johannes, et al.
Publicado: (2018)

Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome
por: Lövdahl, Jenny, et al.
Publicado: (2022)

Mo1018: THE T-CELL RESPONSE TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS OFTEN DEFICIENT IN ANTIBODY-RESPONDERS, AND AUGMENTED BY ANTI-TNF THERAPY
por: Li, Dalin, et al.
Publicado: (2022)

The Efficacy of Hypnotherapy in the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis
por: Lee, Han Hee, et al.
Publicado: (2014)

Mo1021: THE EFFECT OF HIDDEN CELIAC DISEASE ON COVID-19 IN THE COMMUNITY
por: Choung, Rok Seon, et al.
Publicado: (2022)

Mo1087: MALADAPTIVE BEHAVIORS IN PERSONS WITH IBD DURING THE COVID-19 PANDEMIC
por: Shaffer, Seth R., et al.
Publicado: (2022)

Mo1000: DISPARITIES IN HEALTHCARE UTILIZATION BEFORE, DURING, AND AFTER THE COVID-19 PANDEMIC LOCKDOWN
por: Sanaka, Harsha, et al.
Publicado: (2022)

Mo1074: FELLOW EXPERIENCES WITH ENDOSCOPY SIMULATION BEFORE AND DURING THE COVID-19 PANDEMIC: AN INTERNATIONAL SURVEY
por: Lee, Briton, et al.
Publicado: (2022)

Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial
por: Hoekman, Daniël R, et al.
Publicado: (2020)

Mo1358: IMPACT OF SARS-COV-2 INFECTION ON RECIPIENTS OF LIVER TRANSPLANT. REPORT OF A MEXICAN COHORT.
por: Azamar-Llamas, Daniel, et al.
Publicado: (2022)

Sa1066: SURVEY OF NYC PEDIATRIC INSTITUTIONS SUGGESTS POSSIBLE INCREASE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE DIAGNOSIS ASSOCIATED WITH PREVALENCE OF COVID INFECTION
por: Ochoa, Kenny J. Castro, et al.
Publicado: (2022)

General practitioners believe that hypnotherapy could be a useful treatment for irritable bowel syndrome in primary care
por: Cox, Stephen, et al.
Publicado: (2004)

The mind–body connection in irritable bowel syndrome: A randomised controlled trial of hypnotherapy as a treatment
por: Phillips-Moore, Julie S, et al.
Publicado: (2015)

Mo1020: GUT MICROBIOME CHANGES ASSOCIATED WITH HIGHER AND LONGER-LASTING ANTIBODY TITERS FOLLOWING COVID-19 VACCINATION
por: Venzon, Mericien M., et al.
Publicado: (2022)

Mo1623: FOODS OR FADS? OUTCOMES OF KETOGENIC, PLANT-BASED, AND INTERMITTENT FASTING DIETS: A SYSTEMATIC REVIEW AND METAANALYSIS
por: Srinivasan, Sachin, et al.
Publicado: (2022)

Mo1054: DIAGNOSTIC STRATEGIES FOR HELICOBACTER PYLORI IN PATIENTS WITH BLEEDING PEPTIC ULCERS UNDERGOING ENDOSCOPY: A COST-EFFECTIVENESS ANALYSIS
por: Artin, Michael G., et al.
Publicado: (2022)

Mo1086: MENTAL HEALTH IN IBD DURING THE COVID-19 PANDEMIC: ACCESS TO MENTAL HEALTH CARE AND EXPOSURE TO PANDEMIC NEWS
por: Shaffer, Seth R., et al.
Publicado: (2022)

Mo1019: THE IMPACT OF IBS ON SELF-REPORTED PHYSICAL AND MENTAL HEALTH DURING THE COVID PANDEMIC – A NORWEGIAN TWIN STUDY
por: Kutschke, Julia, et al.
Publicado: (2022)

Mo1621: DISTINCT PHENOTYPES OF MULTI-ORGAN ABNORMALITIES IN LONG COVID AND TYPE 2 DIABETES IDENTIFIED BY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING
por: Eichert, Nicole, et al.
Publicado: (2022)

Mo1622: EFFICACY OF GLP-1 ANALOGS AND AGONISTS ON PROPORTION OF WEIGHT LOSS IN OVERWEIGHT OR OBESE DIABETICS AND NONDIABETICS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Vosoughi, Kia, et al.
Publicado: (2022)

Mo1620: ECTOPIC FAT DEPOSITION IN THE LIVER AND PANCREAS AND THE PRESENCE OF EXCESS VISCERAL ADIPOSE TISSUE SIGNIFICANTLY INCREASE HOSPITALISATION RISK FOLLOWING COVID-19.
por: Waddell, Tom H., et al.
Publicado: (2022)

Fr501 BIOLOGICS AND COVID-19 OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS
por: Weissman, Simcha, et al.
Publicado: (2021)

The structure of resilience in irritable bowel syndrome and its improvement through hypnotherapy: Cross-sectional and prospective longitudinal data
por: Peter, Johannes, et al.
Publicado: (2018)

On Functional Connectivity and Symptom Relief After Gut-directed Hypnotherapy in Irritable Bowel Syndrome: A Preliminary Study
por: Simon, Rozalyn A, et al.
Publicado: (2019)

EP1270: SEROCONVERSION IN INFLAMMATORY BOWEL DISEASE PATIENTS AFTER COVID-19 VACCINATION
por: Horvath, Miklos, et al.
Publicado: (2022)

Tu1544: HUMORAL AND T CELL RESPONSES TO COVID-19 VACCINATION IN INFLAMMATORY BOWEL DISEASE
por: Zhang, Eva, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2l7tvgq18dp4d7isho2bgdp3b0